http://www.revance.com
Revance Therapeutics, Inc. Company Intro
By selecting "I accept," I authorize Revance, or any contracted third parties acting on its behalf, to install cookies on my browser. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media.
Industry
Healthcare
Revance Therapeutics, Inc. Headquaters
7555 Gateway Boulevard
Newark,94560
United States
Revance Therapeutics, Inc. Share price
21 Jan 2021 02:27 GMT
$28.64
0.14 (0.49 %)
Revance Therapeutics, Inc. Market cap
$1.909 B
WMC RANKING
2021
Revance Therapeutics, Inc. # 285
BiotechnologyLatest Revance Therapeutics, Inc. News
09 Jan 2021
Revance Therapeutics, Inc. (NASDAQ:RVNC): Can A Stock ...
Revance Therapeutics, Inc. (NASDAQ:RVNC)'s traded shares stood at 508,039 during the last session, with the company's beta value hitting 1.42. At the close of ...
09 Jan 2021
Revance Therapeutics, Inc. (NASDAQ:RVNC): Can A Stock ...
Revance Therapeutics, Inc. (NASDAQ:RVNC)'s traded shares stood at 508,039 during the last session, with the company's beta value hitting 1.42. At the close of ...
09 Jan 2021
Revance Therapeutics, Inc. (NASDAQ:RVNC): Can A Stock ...
Revance Therapeutics, Inc. (NASDAQ:RVNC)'s traded shares stood at 508,039 during the last session, with the company's beta value hitting 1.42. At the close of ...
WMC Market Score
WMC Market to Revenue Score
Revance Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Revance Therapeutics, Inc. | USD | $413 | $164,872 | $-159,429 | $19,090B | 285 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $578,630B | 1 |
| Alexion Pharmaceuticals, Inc. | USD | $5,862,400 | $2,588,400 | $956,600 | $345,010B | 2 |
| Vertex Pharmaceuticals Incorporated | USD | $5,991,128 | $2,596,854 | $2,690,691 | $615,510B | 3 |
| ALK-Abello A/S | USD | $3,383,000 | $1,831,000 | $43,000 | $276,870B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Revance Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Revance Therapeutics, Inc. Post vs Top 4 Industry Competitors
Revance Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Revance Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Revance Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Revance Therapeutics, Inc. | 0.00 | 5.71 | 8.37 | 0 | 0 | 0 | 7.22 |
| Regeneron Pharmaceuticals, Inc. | 100 | 66.01 | 28.87 | 100 | 0 | 0 | 100 |
| Alexion Pharmaceuticals, Inc. | 63.42 | 16.23 | 100 | 60 | 0 | 0 | 90.49 |
| Vertex Pharmaceuticals Incorporated | 64.81 | 100 | 8.79 | 86 | 0 | 0 | 99.87 |
| ALK-Abello A/S | 36.60 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
